rs34637584
|
|
A |
0.810 |
CausalMutation |
CLINVAR |
Quantitative assessment of the effect of LRRK2 exonic variants on the risk of Parkinson's disease: a meta-analysis.
|
22575234 |
2012 |
rs34637584
|
|
A |
0.810 |
CausalMutation |
CLINVAR |
Pathogenic LRRK2 mutations, through increased kinase activity, produce enlarged lysosomes with reduced degradative capacity and increase ATP13A2 expression.
|
26251043 |
2015 |
rs34637584
|
|
A |
0.810 |
CausalMutation |
CLINVAR |
The Gly2019Ser mutation in LRRK2 is not fully penetrant in familial Parkinson's disease: the GenePD study.
|
18986508 |
2008 |
rs34637584
|
|
A |
0.810 |
CausalMutation |
CLINVAR |
Identification of a novel LRRK2 mutation linked to autosomal dominant parkinsonism: evidence of a common founder across European populations.
|
15726496 |
2005 |
rs34637584
|
|
A |
0.810 |
CausalMutation |
CLINVAR |
Genetic screening for a single common LRRK2 mutation in familial Parkinson's disease.
|
15680455 |
2005 |
rs33939927
|
|
T |
0.800 |
CausalMutation |
CLINVAR |
Kinase activity is required for the toxic effects of mutant LRRK2/dardarin.
|
16750377 |
2006 |
rs33939927
|
|
G |
0.800 |
CausalMutation |
CLINVAR |
|
|
|
rs33939927
|
|
T |
0.800 |
CausalMutation |
CLINVAR |
Dopaminergic neuronal loss, reduced neurite complexity and autophagic abnormalities in transgenic mice expressing G2019S mutant LRRK2.
|
21494637 |
2011 |
rs33939927
|
|
T |
0.800 |
CausalMutation |
CLINVAR |
The LRRK2 R1441C mutation is more frequent than G2019S in Parkinson's disease patients from southern Italy.
|
21538529 |
2011 |
rs33939927
|
|
T |
0.800 |
CausalMutation |
CLINVAR |
Mutations in LRRK2 cause autosomal-dominant parkinsonism with pleomorphic pathology.
|
15541309 |
2004 |
rs33939927
|
|
T |
0.800 |
CausalMutation |
CLINVAR |
LRRK2 directly phosphorylates Akt1 as a possible physiological substrate: impairment of the kinase activity by Parkinson's disease-associated mutations.
|
21658387 |
2011 |
rs33939927
|
|
T |
0.800 |
CausalMutation |
CLINVAR |
Ser1292 autophosphorylation is an indicator of LRRK2 kinase activity and contributes to the cellular effects of PD mutations.
|
23241745 |
2012 |
rs33939927
|
|
T |
0.800 |
CausalMutation |
CLINVAR |
Analysis of non-synonymous-coding variants of Parkinson's disease-related pathogenic and susceptibility genes in East Asian populations.
|
24565865 |
2014 |
rs34805604
|
|
G |
0.800 |
CausalMutation |
CLINVAR |
|
|
|
rs34995376
|
|
A |
0.800 |
CausalMutation |
CLINVAR |
|
|
|
rs35801418
|
|
G |
0.800 |
CausalMutation |
CLINVAR |
|
|
|
rs35870237
|
|
C |
0.800 |
CausalMutation |
CLINVAR |
|
|
|
rs281865052
|
|
G |
0.700 |
CausalMutation |
CLINVAR |
|
|
|
rs281865054
|
|
T |
0.700 |
CausalMutation |
CLINVAR |
|
|
|
rs74163686
|
|
C |
0.700 |
CausalMutation |
CLINVAR |
|
|
|
rs34637584
|
|
|
0.810 |
GeneticVariation |
UNIPROT |
EFNS/MDS-ES/ENS [corrected] recommendations for the diagnosis of Parkinson's disease.
|
23279440 |
2013 |
rs33939927
|
|
|
0.800 |
GeneticVariation |
UNIPROT |
Rab29 activation of the Parkinson's disease-associated LRRK2 kinase.
|
29212815 |
2018 |
rs33939927
|
|
|
0.800 |
GeneticVariation |
UNIPROT |
Identification of a novel LRRK2 mutation linked to autosomal dominant parkinsonism: evidence of a common founder across European populations.
|
15726496 |
2005 |
rs33939927
|
|
|
0.800 |
GeneticVariation |
UNIPROT |
The G6055A (G2019S) mutation in LRRK2 is frequent in both early and late onset Parkinson's disease and originates from a common ancestor.
|
16272257 |
2005 |
rs33939927
|
|
|
0.800 |
GeneticVariation |
UNIPROT |
Parkinson's disease and LRRK2: frequency of a common mutation in U.S. movement disorder clinics.
|
16250030 |
2006 |